Serum Phosphorus, Parathyroid Hormone, and Serum Fibroblast Growth Factor-23 in Egyptian Patients Six Months after Undergoing Living-donor Kidney Transplantation

Serum Phosphorus, Parathyroid Hormone, and Serum Fibroblast Growth Factor-23 in Egyptian Patients Six Months after Undergoing Living-donor Kidney Transplantation

End-stage renal disease is a major health problem with many complications. Previous studies emphasized the relationship of cardiovascular disease and mortality among these patients to dysregulated phosphate homeostasis. Even after successful renal transplantation, the risk is not eliminated. Several...

Full description

Bibliographic Details
Main Authors: Mai Hamed Kamel, Dina Hesham Ahmed, Emily Samir Mikhael, Mohamed Shehata Abdalla, Khaled Marzouk Sadek, Maggie Said ElNahid
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=3;spage=353;epage=360;aulast=Kamel

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=3;spage=353;epage=360;aulast=Kamel

Similar Items